Yang et al. further evaluated the LDL-DHA on human liver cancer stem cells (CSC) and found that CSCs had a lower survival rate than normal cancer cells for the different LDLR expression [39], verifying LDL as a suitable delivery platform for drug-resistant cancer stem cells. Here, LDLR is linked to cancer.